Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Rani Therapeutics(RANI) predict that the Revenue is 1.708 M (+893%), Beat estimate;the EBIT is -8.339 M (+30.58%), Beat estimate;the EPS is -0.04 (+81.82%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B893.02%
0.00B190.70%
+0.00B702.32%
EBITExceed expectations
-0.01B30.58%
-0.01B13.93%
+0.00B16.65%
EPSExceed expectations
-0.0481.82%
-0.043380.30%
+0.00331.52%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf